130 related articles for article (PubMed ID: 11949843)
21. Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study.
Briasoulis E; Tsokos M; Fountzilas G; Bafaloukos D; Kosmidis P; Samantas E; Skarlos D; Nicolaides C; Pavlidis N
Anticancer Res; 1998; 18(3B):1907-14. PubMed ID: 9677443
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
23. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer.
Neri A; Marrelli D; Roviello F; DeMarco G; Mariani F; DeStefano A; Megha T; Caruso S; Corso G; Cioppa T; Pinto E
Breast Cancer Res Treat; 2006 Sep; 99(1):77-83. PubMed ID: 16541314
[TBL] [Abstract][Full Text] [Related]
26. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
27. Significance of p53 expression in immature teratomas.
Charoenkwan P; Senger C; Weitzman S; Sexsmith E; Sherman CG; Malkin D; Thorner PS
Pediatr Dev Pathol; 2002; 5(5):499-507. PubMed ID: 12202994
[TBL] [Abstract][Full Text] [Related]
28. [Detection and evaluation of bcl-x and bcl-2 gene expression in blasts from patients with acute leukemia].
Shen X; Wang C; Qiao Z
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):350-3. PubMed ID: 11721430
[TBL] [Abstract][Full Text] [Related]
29. [Presence of bcl-2 and p53 proteins in patients with non-Hodgkin's lymphoma at Zadar General Hospital].
Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
Acta Med Croatica; 2004; 58(3):183-6. PubMed ID: 15503680
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometry of p53 protein expression in some hematological malignancies.
Koníková E; Kusenda J; Babusíková O
Neoplasma; 1999; 46(6):368-76. PubMed ID: 10732866
[TBL] [Abstract][Full Text] [Related]
31. bcl2, p53 and bax in thyroid tumors and their relation to apoptosis.
Farid P; Gomb SZ; Péter I; Szende B
Neoplasma; 2001; 48(4):299-301. PubMed ID: 11712682
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
33. Transcription of genes of p53-dependent apoptosis in acute leukaemia.
Racay P; Hatok J; Hudecek J; Chudej J; Jurecekova J; Dobrota D
Int J Mol Med; 2008 Dec; 22(6):833-9. PubMed ID: 19020783
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
Nakagawa Y; Yamaguchi S; Hasegawa M; Nemoto T; Inoue M; Suzuki K; Hirokawa K; Kitagawa M
Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
[TBL] [Abstract][Full Text] [Related]
35. Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas.
Ilyas M; Kendall M; Jalal H; Linton C; Rooney N
J Pathol; 1996 Nov; 180(3):249-53. PubMed ID: 8958800
[TBL] [Abstract][Full Text] [Related]
36. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH
Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898
[TBL] [Abstract][Full Text] [Related]
38. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
Kalomenidis I; Orphanidou D; Papamichalis G; Vassilakopoulos T; Scorilas A; Rasidakis A; Papastamatiou H; Jordanoglou J; Roussos C
Lung; 2001; 179(5):265-78. PubMed ID: 11976895
[TBL] [Abstract][Full Text] [Related]
39. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
40. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Scalvenzi M; Salvatore G; Errico ME; Fanali S; De Rosa G; Piattelli A
Anticancer Res; 2001; 21(6A):3757-64. PubMed ID: 11911244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
